IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
-
Published:2024-08
Issue:
Volume:137
Page:112424
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Shen JianboORCID,
Qian Niliang,
Xu Guili,
Dou Xiaoqian,
An Ying,
Yang Cuima,
Liu Yujie,
Liu Yunhui,
Pan Xiujie,
Wang Jingjing,
Bai Guijun,
Chen Hao,
Zhu Xiaolin,
Gao Xin,
Zhou GuoxiongORCID,
Xu Qinzhi
Reference52 articles.
1. Cancer statistics, 2023;Siegel;CA Cancer J. Clin.,2023
2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021
3. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;Collaborators;Lancet Gastroenterol. Hepatol.,2022
4. Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults;Stoffel;Gastroenterology,2020
5. Colorectal cancer statistics, 2023;Siegel;CA Cancer J. Clin.,2023